Cargando…
Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746919/ https://www.ncbi.nlm.nih.gov/pubmed/33339537 http://dx.doi.org/10.1186/s40164-020-00195-x |
_version_ | 1783624893703651328 |
---|---|
author | Muntañola, Ana Villacampa, Guillermo Hernández-Rivas, José Ángel Alonso, Rosalía Mirás, Fátima Osorio, Santiago Baile, Mónica Baltasar, Patricia López Jiménez, Javier Hernandez-Rodriguez, Ines Valenciano, Susana Alfayate, Ana Gimeno, Eva Bárez, Abelardo Oliveira, Ana C. Riaza, Rosalía Romero, Pilar Delgado, Julio Yáñez, Lucrecia Zabalza, Amaya Torres, Ana Gómez-Roncero, Mª Isabel Crespo, Marta Córdoba, Raúl Mateos-Mazón, Juan José Pérez, Sonia Andreu, Rafael Labrador, Jorge Ruiz, Mª Elena Velasquez, César Andrés Terol, Mª José Santiago, Raquel Vidal, Mª Jesús Campoy García, Fiz Villalón, Lucía Muiña, Begoña S. Soler, Joan Alfons Seri, Cristina Sánchez, Mª José Cuesta, Amalia Ramos, Rafael Sánchez-Montalvá, Adrián Ruiz-Camps, Isabel González, Marcos Abrisqueta, Pau Bosch, Francesc |
author_facet | Muntañola, Ana Villacampa, Guillermo Hernández-Rivas, José Ángel Alonso, Rosalía Mirás, Fátima Osorio, Santiago Baile, Mónica Baltasar, Patricia López Jiménez, Javier Hernandez-Rodriguez, Ines Valenciano, Susana Alfayate, Ana Gimeno, Eva Bárez, Abelardo Oliveira, Ana C. Riaza, Rosalía Romero, Pilar Delgado, Julio Yáñez, Lucrecia Zabalza, Amaya Torres, Ana Gómez-Roncero, Mª Isabel Crespo, Marta Córdoba, Raúl Mateos-Mazón, Juan José Pérez, Sonia Andreu, Rafael Labrador, Jorge Ruiz, Mª Elena Velasquez, César Andrés Terol, Mª José Santiago, Raquel Vidal, Mª Jesús Campoy García, Fiz Villalón, Lucía Muiña, Begoña S. Soler, Joan Alfons Seri, Cristina Sánchez, Mª José Cuesta, Amalia Ramos, Rafael Sánchez-Montalvá, Adrián Ruiz-Camps, Isabel González, Marcos Abrisqueta, Pau Bosch, Francesc |
author_sort | Muntañola, Ana |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7746919 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-77469192020-12-18 Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country Muntañola, Ana Villacampa, Guillermo Hernández-Rivas, José Ángel Alonso, Rosalía Mirás, Fátima Osorio, Santiago Baile, Mónica Baltasar, Patricia López Jiménez, Javier Hernandez-Rodriguez, Ines Valenciano, Susana Alfayate, Ana Gimeno, Eva Bárez, Abelardo Oliveira, Ana C. Riaza, Rosalía Romero, Pilar Delgado, Julio Yáñez, Lucrecia Zabalza, Amaya Torres, Ana Gómez-Roncero, Mª Isabel Crespo, Marta Córdoba, Raúl Mateos-Mazón, Juan José Pérez, Sonia Andreu, Rafael Labrador, Jorge Ruiz, Mª Elena Velasquez, César Andrés Terol, Mª José Santiago, Raquel Vidal, Mª Jesús Campoy García, Fiz Villalón, Lucía Muiña, Begoña S. Soler, Joan Alfons Seri, Cristina Sánchez, Mª José Cuesta, Amalia Ramos, Rafael Sánchez-Montalvá, Adrián Ruiz-Camps, Isabel González, Marcos Abrisqueta, Pau Bosch, Francesc Exp Hematol Oncol Letter to the Editor BioMed Central 2020-12-18 /pmc/articles/PMC7746919/ /pubmed/33339537 http://dx.doi.org/10.1186/s40164-020-00195-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Letter to the Editor Muntañola, Ana Villacampa, Guillermo Hernández-Rivas, José Ángel Alonso, Rosalía Mirás, Fátima Osorio, Santiago Baile, Mónica Baltasar, Patricia López Jiménez, Javier Hernandez-Rodriguez, Ines Valenciano, Susana Alfayate, Ana Gimeno, Eva Bárez, Abelardo Oliveira, Ana C. Riaza, Rosalía Romero, Pilar Delgado, Julio Yáñez, Lucrecia Zabalza, Amaya Torres, Ana Gómez-Roncero, Mª Isabel Crespo, Marta Córdoba, Raúl Mateos-Mazón, Juan José Pérez, Sonia Andreu, Rafael Labrador, Jorge Ruiz, Mª Elena Velasquez, César Andrés Terol, Mª José Santiago, Raquel Vidal, Mª Jesús Campoy García, Fiz Villalón, Lucía Muiña, Begoña S. Soler, Joan Alfons Seri, Cristina Sánchez, Mª José Cuesta, Amalia Ramos, Rafael Sánchez-Montalvá, Adrián Ruiz-Camps, Isabel González, Marcos Abrisqueta, Pau Bosch, Francesc Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country |
title | Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country |
title_full | Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country |
title_fullStr | Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country |
title_full_unstemmed | Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country |
title_short | Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country |
title_sort | clinical characteristics and outcome of sars-cov-2 infection in admitted patients with chronic lymphocytic leukemia from a single european country |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746919/ https://www.ncbi.nlm.nih.gov/pubmed/33339537 http://dx.doi.org/10.1186/s40164-020-00195-x |
work_keys_str_mv | AT muntanolaana clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT villacampaguillermo clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT hernandezrivasjoseangel clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT alonsorosalia clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT mirasfatima clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT osoriosantiago clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT bailemonica clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT baltasarpatricia clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT lopezjimenezjavier clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT hernandezrodriguezines clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT valencianosusana clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT alfayateana clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT gimenoeva clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT barezabelardo clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT oliveiraanac clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT riazarosalia clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT romeropilar clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT delgadojulio clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT yanezlucrecia clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT zabalzaamaya clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT torresana clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT gomezronceromaisabel clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT crespomarta clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT cordobaraul clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT mateosmazonjuanjose clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT perezsonia clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT andreurafael clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT labradorjorge clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT ruizmaelena clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT velasquezcesarandres clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT terolmajose clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT santiagoraquel clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT vidalmajesus clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT campoygarciafiz clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT villalonlucia clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT muinabegonas clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT solerjoanalfons clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT sericristina clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT sanchezmajose clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT cuestaamalia clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT ramosrafael clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT sanchezmontalvaadrian clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT ruizcampsisabel clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT gonzalezmarcos clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT abrisquetapau clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT boschfrancesc clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry AT clinicalcharacteristicsandoutcomeofsarscov2infectioninadmittedpatientswithchroniclymphocyticleukemiafromasingleeuropeancountry |